Nisa Investment Advisors
SNDX icon

Nisa Investment Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History

Nisa Investment Advisors’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.5K Buy
1,133
+21
+2% +$456 ﹤0.01% 1910
2025
Q4 		$23.4K Hold
1,112
– – ﹤0.01% 1880
2025
Q3 		$17.1K Buy
1,112
+11
+1% +$144 ﹤0.01% 2063
2025
Q2 		$10.3K Buy
1,101
+222
+25% +$2.44K ﹤0.01% 2248
2025
Q1 		$10.8K Buy
879
+61
+7% +$860 ﹤0.01% 2079
2024
Q4 		$10.8K Sell
818
-243
-23% -$4.16K ﹤0.01% 2115
2024
Q3 		$20.4K Buy
1,061
+49
+5% +$1.01K ﹤0.01% 1900
2024
Q2 		$20.8K Buy
1,012
+908
+873% +$19K ﹤0.01% 1922
2024
Q1 		$2.48K Buy
104
+69
+197% +$1.54K ﹤0.01% 2200
2023
Q4 		$756 Sell
35
-29
-45% -$446 ﹤0.01% 2323
2023
Q3 		$929 Sell
64
-1,368
-96% -$25.9K ﹤0.01% 2406
2023
Q2 		$30K Buy
1,432
+580
+68% +$12.1K ﹤0.01% 1940
2023
Q1 		$18K Buy
852
+810
+1,929% +$20.1K ﹤0.01% 2043
2022
Q4 		$1K Hold
42
– – ﹤0.01% 2501
2022
Q3 		$1K Buy
+42
New +$942 ﹤0.01% 2504
2022
Q2 		– Sell
-2,160
Closed -$38K – 2498
2022
Q1 		$38K Hold
2,160
– – ﹤0.01% 1914
2021
Q4 		$35K Sell
2,160
-240
-10% -$4.43K ﹤0.01% 1813
2021
Q3 		$46 Hold
2,400
– – ﹤0.01% 1956
2021
Q2 		$41 Buy
2,400
+1,900
+380% +$34.8K ﹤0.01% 1989
2021
Q1 		$11 Hold
500
– – ﹤0.01% 2200
2020
Q4 		$11K Buy
+500
New +$10.4K ﹤0.01% 2203

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Nisa Investment Advisors's SNDX Position: Q1 2026 in Review

Nisa Investment Advisors increased its Syndax Pharmaceuticals (SNDX) stake by 1.9% in Q1 2026, buying an estimated $456 and bringing the position to 1,133 shares worth $26.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1910.

Nisa Investment Advisors first reported a position in SNDX in Q4 2020 and has held it in 21 quarters since. The position peaked at $38K in Q1 2022. 247 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Nisa Investment Advisors held 1,133 shares of Syndax Pharmaceuticals worth $26.5K as of Q1 2026.
  • Nisa Investment Advisors bought 21 Syndax Pharmaceuticals shares in Q1 2026, an estimated $456.
  • Syndax Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1910 holding.
  • Nisa Investment Advisors first reported a position in Syndax Pharmaceuticals in Q4 2020 and has held it in 21 quarters since.
  • Nisa Investment Advisors's Syndax Pharmaceuticals position peaked at $38K in Q1 2022.
  • 247 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.